According to the Food and Drug Administration (FDA) there is a national shortage of doxycycline because of manufacturing issues and an increased demand for the drug due to shortages of other drugs. Doxycycline is used both in prevention and treatment of malaria. There are several manufacturers in the US, some of whom are still supplying doxycycline on a limited basis. FDA is currently contacting and working with the companies and expediting all regulatory actions to allow additional product availability. Additionally, FDA is continuing to monitor the situation and will post additional information on their webpage in the near future.
The Centers for Disease Control and Prevention will update this notice as new information becomes available.
Information about this drug shortage and other drug shortages can be found from the American Society of Health-System Pharmacists (ASHP).
For more information about recommended antimalarial drugs by country, see Malaria Endemic Areas by Country.
For general information about antimalarial drugs, see Drugs for Prevention.
Get email updates about Malaria
To receive email updates about this page, enter your email address:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333
- Health care providers needing assistance with diagnosis or management of suspected cases of malaria should call the CDC Malaria Hotline:
770-488-7788 or 855-856-4713 toll-free
(M-F, 9am-5pm, eastern time).
- Emergency consultation after hours, call:
and request to speak with a CDC Malaria Branch clinician.